90,000 Shares in Arteris, Inc. $AIP Acquired by Acuitas Investments LLC

Key Points

• Acuitas Investments LLC acquired 90,000 shares of Arteris, Inc. for approximately $858,000, marking a new position for the firm as of the latest SEC disclosure.
• Arteris reported revenues of $16.50 million for the last quarter, exceeding estimates, but also posted a negative net margin of 52.41%.
• Insider trading includes CEO K Charles Janac selling 50,000 shares for $653,500, reducing their stake by 0.51%, while overall, 29.10% of the stock is owned by corporate insiders.

Acuitas Investments LLC purchased a new position in shares of Arteris, Inc. (NASDAQ:AIP - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 90,000 shares of the company's stock, valued at approximately $858,000. Acuitas Investments LLC owned 0.21% of Arteris as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of AIP. CWM LLC raised its stake in shares of Arteris by 4,810.1% in the first quarter. CWM LLC now owns 10,213 shares of the company's stock worth $71,000 after purchasing an additional 10,005 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Arteris in the first quarter worth approximately $95,000. Kapitalo Investimentos Ltda purchased a new stake in shares of Arteris in the second quarter worth approximately $104,000. Strs Ohio bought a new position in shares of Arteris in the first quarter valued at approximately $104,000. Finally, Ieq Capital LLC bought a new position in shares of Arteris in the first quarter valued at approximately $177,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

Arteris Price Performance

NASDAQ:AIP opened at $13.83 on Friday. The company has a market cap of $589.85 million, a P/E ratio of -16.87 and a beta of 1.45. The stock's fifty day moving average price is $10.62 and its two-hundred day moving average price is $9.01. Arteris, Inc. has a 1 year low of $5.46 and a 1 year high of $14.88.

Arteris (NASDAQ:AIP - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported ($0.11) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.11). The firm had revenue of $16.50 million for the quarter, compared to the consensus estimate of $16.35 million. Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, analysts expect that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO K Charles Janac sold 50,000 shares of the stock in a transaction on Wednesday, October 8th. The stock was sold at an average price of $13.07, for a total value of $653,500.00. Following the sale, the chief executive officer owned 9,689,071 shares in the company, valued at approximately $126,636,157.97. This trade represents a 0.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Nicholas B. Hawkins sold 6,421 shares of the stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $13.21, for a total value of $84,821.41. Following the completion of the sale, the chief financial officer owned 93,590 shares in the company, valued at $1,236,323.90. This trade represents a 6.42% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 810,800 shares of company stock valued at $10,089,160. 29.10% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Wall Street Zen raised Arteris from a "sell" rating to a "hold" rating in a report on Monday, September 15th. Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a report on Wednesday, October 8th. Finally, TD Cowen increased their price objective on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $15.00.

Arteris Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.